Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IT'S NEVER A BAD IDEA TO CASH OUT !!!
I'M ROLLING THE DICE HERE !!
im out ...sideline
ONE DOLLAR IS NEXT. THE STREET IS UNDERESTIMATING THE NEWS
Let's bring her down easy, so I can load up again!!!!
Only 2.75m shares dilution. Not even a factor
yup but could blow up when they stop
Nice Congratulations 🎊 it’ll be nice waking up to 100-200 k Enjoy yourself today
You won
Congrats!
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
I’m in 350k of shares win or lose. They got some good pipeline in cancer drugs will be taken out
I beleave we have an explosive situation going on right now Go Farrowtech!!!!!
Hey, they finished shaving, .235692, down here... 😸
Nice grabs...
Grabbed .24s and .25s this round
I may avg down a little more, thanks, tw0122 🙂
Warrants exercise(d) @ .237...looking for a sizable pOp for all these 'good fellows', lol...
Scalped it on the earlier run. Going to add some under .30
I'm in, unfortunately @ avg pps .37... 🤨
Still think she'll pOp back UP over .60 this week...
Go for it .32 now and running again .51 is resistance again
$MBIO trying to buy some of this @ .51, hard to execute premarket, she gonna pOp...JMO
MBIO.................................https://stockcharts.com/h-sc/ui?s=MBIO&p=W&b=5&g=0&id=p86431144783
Already read it earlier this morning
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
the study, which is the largest reported trial to date of CAR T therapy for solid tumors, evaluated CAR T cells engineered to target the tumor-associated antigen interleukin-13 receptor alpha 2 (IL13Ra2), a product invented at City of Hope and exclusively licensed by Mustang Bio Inc. (Nasdaq: MBIO), a Fortress Biotech Inc. (Nasdaq: FBIO) Company.
https://www.businesswire.com/news/home/20240307463963/en/
Probably new caused the run
Three or four years ago stocks of clinical trial biomed companies could do no wrong
Institutional asset managers accumulated large amounts of shares and continued buying even though most sold more shares to raise more money to replace the money they burned through
When the US central bank raised interest rates the asset managers started selling these shares
This will continue until the US central bank reverses course and begins lowering interest rates
Nothing a POS
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194
|
Created
|
08/24/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |